Support our sponsors:

NZX 50 Index	3326.74	0.00
S&P/ASX 200	4282.90	7.80
Dow Jones Industrials	12884.00	5.80

Twitter

Facebook

RSS

Daily ShareChat: Fisher and Paykel Healthcare

By Jenny Ruth

Tuesday 29th June 2010

Text too small?

Fisher & Paykel Healthcare is a high quality company with substantial growth opportunities, says Craigs Investment Partners.

“On the basis of our forecasts, which assume the group can continue to deliver on its ambitious medium growth plans, the stock offers valuation appeal, trading at a 20% discount (when trading at $3.16) to our DCF (discounted cashflow)-derived intrinsic value estimate,” the broker says.

It expects new product launches will mean the company's core businesses will continue to grow strongly.

Its respiratory and acute care division will continue to leverage its technological expertise in respiratory humidification to move into associated market segments, progressively widening its addressable market.

Craigs says Fisher & Paykel's management estimates as new products currently under development are launched, the company's addressable market will potentially quadruple.

“This opportunity, coupled with underlying market growth driven by favourable demographic trends, underpins management's 15% medium term volume growth assumption.”

Its new ICON range of flow generators used to treat obstructive sleep apnea should lead to accelerated growth in the second half of 2011, Craigs says.

Craigs is assuming 15% volume growth from that division also, in line with management guidance. While, as an exporter, the company is exposed to exchange rate movements, it is substantially hedged for its 2011 financial year, the broker says.

Recommendation: Buy.

Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Printable version

Get quotes for Fisher & Paykel Healthcare Corporation L (FPH)

NZX Annoucements for FPH

9 Feb 2012	RELINT: FPH: Disclosure of Directors Relevant Interests
9 Feb 2012	GENERAL: FPH: CAREFUSION & FPH RENEW EXCLUSIVE DISTRIBUTION AGREEMENT
31 Jan 2012	SSH: FPH: SSH Mondrian Investment Partners Limited
11 Jan 2012	ALLOT: FPH: NOTIFICATION OF ISSUE OF SECURITIES